AMERICAN CENTURY COMPANIES INC - ALDER BIOPHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
AMERICAN CENTURY COMPANIES INC ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$2,365,000
+18.5%
200,940
+37.4%
0.00%0.0%
Q1 2019$1,996,000
+27.0%
146,221
-4.7%
0.00%0.0%
Q4 2018$1,572,000
-45.1%
153,387
-10.8%
0.00%
-33.3%
Q3 2018$2,863,000
+4.6%
171,976
-0.7%
0.00%0.0%
Q2 2018$2,737,000
+94.9%
173,235
+56.7%
0.00%
+200.0%
Q1 2018$1,404,000
+19.9%
110,531
+8.1%
0.00%0.0%
Q4 2017$1,171,000
-6.9%
102,273
-0.4%
0.00%0.0%
Q3 2017$1,258,000
+20.6%
102,731
+12.8%
0.00%0.0%
Q2 2017$1,043,000
-28.9%
91,052
+29.2%
0.00%
-50.0%
Q1 2017$1,466,000
+5.7%
70,486
+5.7%
0.00%
+100.0%
Q4 2016$1,387,000
-47.4%
66,671
-17.2%
0.00%
-66.7%
Q3 2016$2,638,000
+36.8%
80,498
+4.2%
0.00%
+50.0%
Q2 2016$1,929,000
+7.9%
77,244
+5.9%
0.00%0.0%
Q1 2016$1,787,000
-28.6%
72,970
-3.7%
0.00%
-33.3%
Q4 2015$2,502,000
+10.9%
75,737
+9.9%
0.00%0.0%
Q3 2015$2,257,000
-32.3%
68,908
+9.4%
0.00%
-25.0%
Q2 2015$3,336,000
+53.4%
62,983
-16.4%
0.00%
+100.0%
Q1 2015$2,174,00075,3360.00%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Novo Holdings A/S 3,201,183$40,591,0003.96%
Cormorant Asset Management, LP 150,000$1,902,0000.39%
PFM Health Sciences, LP 1,034,030$13,112,0000.30%
Partner Investment Management, L.P. 23,660$300,0000.11%
PointState Capital LP 375,000$4,755,0000.09%
Spark Investment Management LLC 38,400$486,0000.07%
SECTORAL ASSET MANAGEMENT INC 89,300$1,132,0000.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 95,722$1,214,0000.05%
CADIAN CAPITAL MANAGEMENT, LP 120,000$1,522,0000.04%
Nicholas Investment Partners, LP 49,341$626,0000.04%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders